ArticleNature cancer2025

Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy.

Maria Caterina Rotiroti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.